Venture
![Bow Therapeautics Logo Bow Therapeautics Logo](https://firstxfounder.com/wp-content/uploads/2019/08/Bow-Therapeautics-Logo-1024x1024.png)
Affiliations
Albert Einstein College of Medicine
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Drug Discovery
Infectious Disease
Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.
Bow Therapeutics Team: